Terminology Service for NFDI4Health
All terms in DOID
| Label | Id | Description |
|---|---|---|
| obsolete CNS metastases | DOID_928 | |
| obsolete metastatic malignant neoplasm to brain | DOID_927 | |
| obsolete childhood liver neoplasm | DOID_920 | |
| hemangioblast | CL_0002418 | |
| limb nerve | UBERON_0003440 | |
| duodenum | UBERON_0002114 | |
| peliosis hepatis | DOID_914 | |
| jejunum | UBERON_0002115 | |
| atrophic muscular disease | DOID_913 | [A neuromuscular disease that is characterized by an abnormal reduction in the muscle volume and atrophy.] |
| liver inflammatory pseudotumor | DOID_918 | |
| liver leiomyoma | DOID_917 | |
| occipital lobe neoplasm | DOID_910 | |
| Clostridia | NCBITaxon_186801 | |
| gastrointestinal lymphoma | DOID_903 | |
| obsolete malignant non-epithelial hepatic and intrahepatic bile duct neoplasm | DOID_902 | |
| liver lymphoma | DOID_901 | |
| hepatopulmonary syndrome | DOID_900 | |
| liver fibroma | DOID_907 | |
| Zellweger syndrome | DOID_905 | [A peroxisomal biogenesis disorder that is characterized by the reduction or absence of functional peroxisomes in the cells of an individual that has_material_basis_in autosomal recessive inheritance of a mutation in the peroxisome biogenesis factor (PEX) genes.] |
| primary hyperoxaluria type 2 | DOID_0111671 | [A primary hyperoxaluria characterized by elevated urinary excretion of oxalate and L-glycerate, recurrent nephrolithiasis and nephrocalcinosis, and end-stage renal disease that has_material_basis_in homozygous or compound heterozygous mutation in GRHPR on chromosome 9p13.2.] |